311 related articles for article (PubMed ID: 28288791)
1. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
Saadoun D; Pol S; Ferfar Y; Alric L; Hezode C; Si Ahmed SN; de Saint Martin L; Comarmond C; Bouyer AS; Musset L; Poynard T; Resche Rigon M; Cacoub P
Gastroenterology; 2017 Jul; 153(1):49-52.e5. PubMed ID: 28288791
[TBL] [Abstract][Full Text] [Related]
2. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
3. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
Cacoub P; Si Ahmed SN; Ferfar Y; Pol S; Thabut D; Hezode C; Alric L; Comarmond C; Ragab G; Quartuccio L; Hegazy M; Poynard T; Resche Rigon M; Saadoun D
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):518-526. PubMed ID: 29857143
[TBL] [Abstract][Full Text] [Related]
4. Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study.
Saadoun D; Thibault V; Si Ahmed SN; Alric L; Mallet M; Guillaud C; Izzedine H; Plaisier A; Fontaine H; Costopoulos M; Le Garff-Tavernier M; Hezode C; Pol S; Musset L; Poynard T; Cacoub P
Ann Rheum Dis; 2016 Oct; 75(10):1777-82. PubMed ID: 26567178
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.
Leroy V; Dumortier J; Coilly A; Sebagh M; Fougerou-Leurent C; Radenne S; Botta D; Durand F; Silvain C; Lebray P; Houssel-Debry P; Kamar N; D'Alteroche L; Petrov-Sanchez V; Diallo A; Pageaux GP; Duclos-Vallee JC;
Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1993-2001.e1-2. PubMed ID: 26044317
[TBL] [Abstract][Full Text] [Related]
6. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Saadoun D; Limal N; Sene D; Lidove O; Piette JC
Arthritis Rheum; 2005 Mar; 52(3):911-5. PubMed ID: 15751068
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Gragnani L; Visentini M; Fognani E; Urraro T; De Santis A; Petraccia L; Perez M; Ceccotti G; Colantuono S; Mitrevski M; Stasi C; Del Padre M; Monti M; Gianni E; Pulsoni A; Fiorilli M; Casato M; Zignego AL
Hepatology; 2016 Nov; 64(5):1473-1482. PubMed ID: 27483451
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.
Sise ME; Bloom AK; Wisocky J; Lin MV; Gustafson JL; Lundquist AL; Steele D; Thiim M; Williams WW; Hashemi N; Kim AY; Thadhani R; Chung RT
Hepatology; 2016 Feb; 63(2):408-17. PubMed ID: 26474537
[TBL] [Abstract][Full Text] [Related]
9. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
Front Immunol; 2022; 13():823160. PubMed ID: 35371039
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Mixed Cryoglobulinemia Despite Sustained Virologic Response to Treatment: A Case Report.
Chowdhury R; Tsen A
Am J Kidney Dis; 2017 Aug; 70(2):301-304. PubMed ID: 28343737
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of different antiviral treatment protocols in HCV related cryoglobulinemic vasculitis.
Allam WR; Hegazy MT; Hussein MA; Zoheir N; Quartuccio L; El-Khamisy SF; Ragab G
Sci Rep; 2024 May; 14(1):11840. PubMed ID: 38782988
[TBL] [Abstract][Full Text] [Related]
12. Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study.
Akhil MS; Kirushnan B; Martin M; Arumugam K; Ganesh Prasad NK; Ravichandran R
Nephrology (Carlton); 2018 May; 23(5):446-452. PubMed ID: 28339162
[TBL] [Abstract][Full Text] [Related]
13. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
[TBL] [Abstract][Full Text] [Related]
14. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia.
Calleja JL; Albillos A; Moreno-Otero R; Rossi I; Cacho G; Domper F; Yebra M; Escartín P
Aliment Pharmacol Ther; 1999 Sep; 13(9):1179-86. PubMed ID: 10468699
[TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
Saadoun D; Resche-Rigon M; Thibault V; Piette JC; Cacoub P
Arthritis Rheum; 2006 Nov; 54(11):3696-706. PubMed ID: 17075881
[TBL] [Abstract][Full Text] [Related]
17. A Closing Chapter: Hepatitis C Genotype 3 Elimination in Liver Transplant; Sofosbuvir/Daclatasvir in a Hard-to-Treat Population.
Teegen EM; Globke B; Schott E; Pratschke J; Eurich D
Exp Clin Transplant; 2018 Feb; 16(1):61-67. PubMed ID: 29137590
[TBL] [Abstract][Full Text] [Related]
18. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
Bonacci M; Lens S; Mariño Z; Londoño MC; Rodriguez-Tajes S; Sánchez-Tapias JM; Ramos-Casals M; Hernández-Rodríguez J; Forns X
Gastroenterology; 2018 Aug; 155(2):311-315.e6. PubMed ID: 29705529
[TBL] [Abstract][Full Text] [Related]
20. Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals.
Fayed A; Hegazy MT; Biard L; Vieira M; El Shabony T; Saadoun D; Casato M; Visentini M; Ragab G; Cacoub P
Am J Gastroenterol; 2022 Apr; 117(4):627-636. PubMed ID: 35103020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
